FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
212937NDAFENNEC PHARMS INC001PEDMARKSOLUTION;INTRAVENOUS12.5GM/100ML (125MG/ML)SODIUM THIOSULFATE2022-09-20PrescriptionYes